Skip to main content
ALLERGY THERAPEUTICS PLC logo

ALLERGY THERAPEUTICS PLC — Investor Relations & Filings

Ticker · AGY ISIN · GB00B02LCQ05 LEI · 213800PQ7AHK7KGVOE23 IL Manufacturing
Open in API
Filings indexed 416 across all filing types
Latest filing 2017-03-16 Regulatory Filings
Country GB United Kingdom
Listing IL AGY

About ALLERGY THERAPEUTICS PLC

https://allergytherapeutics.com/

Allergy Therapeutics PLC is an immunology company focused on the research, development, diagnosis, and treatment of allergic disorders. The company specializes in creating therapies for allergy treatment and prevention, with a key focus on developing aluminum-free immunotherapies and allergy vaccines. These treatments aim to address the underlying cause of the allergy rather than merely managing symptoms. Leveraging its specialist expertise in immunology, the company strives to develop effective and convenient solutions to improve the quality of life for individuals with allergies.

Recent filings

Filing Released Lang Actions
First Patient in Pivotal Phase III Birch Study
Regulatory Filings Classification · 98% confidence The document begins with an 'RNS Number' and the date, indicating it is a regulatory announcement disseminated via the Regulatory News Service (RNS) of the London Stock Exchange. The content describes a specific corporate event: the recruitment of the first patient in a Phase III clinical trial for a product called Pollinex® Quattro Birch. This is a material operational update concerning clinical development and future registration plans. While it contains financial/operational news, it is not a full financial report (10-K, IR, ER) nor a management presentation (IP). Since it is a formal, time-sensitive announcement released through the official regulatory channel (RNS), and it doesn't fit neatly into specific categories like Director's Dealing (DIRS), Dividend (DIV), or Capital Change (CAP), the most appropriate classification is the general regulatory announcement category, RNS.
2017-03-16 English
Notice of Interim Results
Report Publication Announcement Classification · 99% confidence The document is very short (2196 characters) and explicitly states its purpose in the title: "Notice of Interim Results". It informs the reader that the company "will issue its interim results for the six months ended 31 December 2016 on Wednesday 29 March 2017." This structure—announcing the future release date and details of a report (Interim Results)—fits the definition of a Report Publication Announcement (RPA). It is not the Interim Report (IR) itself, nor is it a general regulatory filing (RNS), as it pertains specifically to the publication of a known report type.
2017-03-09 English
House Dust Mite Allergy Vaccine Gains CTA Approval
Regulatory Filings Classification · 98% confidence The document begins with an 'RNS Number' and is dated February 14, 2017. It announces a specific corporate event: 'Novel House Dust Mite Allergy Vaccine Gains Clinical Trial Application Approval' and details the progress of a clinical study (Phase I). This type of announcement, which is a formal update on operational or clinical progress, is typically disseminated via regulatory news services. Since it is not a full financial report (10-K, IR), an earnings release (ER), or a management discussion (MDA), and it is clearly a regulatory news service announcement indicated by the 'RNS Number' and the closing tag 'This information is provided by RNS The company news service from the London Stock Exchange', the most appropriate classification is Regulatory Filings (RNS). It is not a Report Publication Announcement (RPA) because it is the primary announcement of the news, not just an announcement that a report is available.
2017-02-14 English
Directorate Change
Board/Management Information Classification · 99% confidence The document explicitly announces a 'Directorate Change' concerning the appointment of Mr. Jeff Barton as a Non-Executive Director and the retirement of Mr. Jean-Yves Pavee. This content directly matches the definition for Board/Management Information. The document is tagged with an 'RNS Number', indicating it is a regulatory announcement, but the specific subject matter points clearly to the 'MANG' category over the general 'RNS' fallback. The length (3623 chars) is not indicative of a full report, but the content is specific enough to classify it precisely.
2017-02-08 English
Grant of Awards
Remuneration Information Classification · 99% confidence The document is identified by the 'RNS Number' header and contains an announcement dated 30 December 2016 regarding the 'Grant of Awards under Long Term Incentive Plan' made to Executive Directors. It explicitly details the number of conditional shares awarded and includes a section titled 'Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them'. This structure strongly indicates a mandatory disclosure of insider transactions or executive remuneration/incentive awards, which falls under Director's Dealing (DIRS) or potentially Remuneration Information (DEF 14A). However, the core content is the notification of the grant of incentive shares to directors (insider transaction/award), which is most closely aligned with Director's Dealing (DIRS) or, given the specific focus on executive compensation structure via LTIPs, could sometimes overlap with DEF 14A. Since it details specific transactions (grant of awards) by named directors, DIRS is a strong candidate. However, the structure closely mirrors the required disclosure format for transactions by PDMRs (Persons Discharging Managerial Responsibilities) which is often captured under DIRS. Given the context of an RNS announcement detailing executive share awards, DIRS (Director's Dealing) is the most appropriate fit for reporting executive transactions/awards, although DEF 14A covers remuneration generally. Since this is a specific transaction notification, DIRS is chosen over the broader DEF 14A, and it is clearly not a general regulatory filing (RNS) because it fits a specific category.
2016-12-30 English
Group of companies' accounts made up to 2016-06-30
Regulatory Filings
2016-12-16 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.